Charles River Laboratories International (CRL) Minority Interest (2009 - 2026)
Charles River Laboratories International (CRL) posted Minority Interest of $42.5 million for Q2 2026, up 1.52% on a QoQ basis from $41.9 million in Q1 2026, and up 6.46% year-over-year from $40.0 million in Q2 2025.
Analysis
Charles River Laboratories International (CRL) Minority Interest (2009 - 2026) Analysis & Trends
Charles River Laboratories International has reported Minority Interest for 18 years, with the latest figure at $42.5 million in Q2 2026.
- On a quarterly basis, Minority Interest rose 6.46% year-over-year to $42.5 million in Q2 2026; TTM through Jun 2026 was $42.5 million, a 6.46% increase from a year earlier, with the FY2025 full-year figure at $41.3 million, changed 0.33% from the prior year.
- Minority Interest was $42.5 million for Q2 2026 at Charles River Laboratories International, up from $41.9 million in the prior quarter.
- The five-year high for Minority Interest was $57.8 million in Q1 2024, with the low at $39.2 million in Q3 2022.
- Average Minority Interest over 5 years is $44.1 million, with a median of $41.8 million recorded in 2025.
- The sharpest annual moves came in 2022 and 2025: Minority Interest surged 99.1% in 2022, then slipped 27.89% in 2025.
- Over 5 years, Minority Interest stood at $42.4 million in 2022, then soared by 33.69% to $56.7 million in 2023, then slipped by 27.5% to $41.1 million in 2024, then grew by 0.33% to $41.3 million in 2025, then advanced by 3.09% to $42.5 million in 2026.
- The last three Minority Interest figures came in at $42.5 million (Q2 2026), $41.9 million (Q1 2026), and $41.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 42.54 Mn |
| Mar 28, 2026 | 41.90 Mn |
| Dec 27, 2025 | 41.26 Mn |
| Sep 27, 2025 | 40.49 Mn |
| Jun 28, 2025 | 39.96 Mn |
| Mar 29, 2025 | 41.66 Mn |
| Dec 28, 2024 | 41.13 Mn |
| Sep 28, 2024 | 40.59 Mn |
| Jun 29, 2024 | 46.08 Mn |
| Mar 30, 2024 | 57.78 Mn |
| Dec 30, 2023 | 56.72 Mn |
| Sep 30, 2023 | 39.95 Mn |
| Jul 1, 2023 | 42.45 Mn |
| Apr 1, 2023 | 42.94 Mn |
| Dec 31, 2022 | 42.43 Mn |
| Sep 24, 2022 | 39.21 Mn |
| Jun 25, 2022 | 40.18 Mn |
| Mar 26, 2022 | 55.82 Mn |
| Dec 25, 2021 | 53.01 Mn |
| Sep 25, 2021 | 32.56 Mn |